Pharmaceutical

HMRI and Novartis Australia sign MoU to expedite medical research

HMRI has signed a memorandum of understanding (MoU) with Novartis Australia for expediting medical research to drive healthcare projects.

Feb 19, 2025 - 06:00
HMRI and Novartis Australia sign MoU to expedite medical research
HMRI has signed a memorandum of understanding (MoU) with Novartis Australia for expediting medical research to drive healthcare projects.
Read the original article

Tags:

Previous Article

FDA to review Sanofi and Regeneron’s Dupixent sBLA for bullous pemphigoid

Next Article

FDA grants fast track status to Rznomics’ RZ-001 for HCC

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Senate committee launches bipartisan investigation into private equity ownership of hospitals

Senate committee launches bipartisan investigation into...

Dec 7, 2023

GSK’s results tease survival benefit trend with Jemperli for endometrial cancer

GSK’s results tease survival benefit trend with Jemperl...

Mar 29, 2023

STAT+: Congress’ negotiations over doc pay, health centers fell apart ahead of spending extension

STAT+: Congress’ negotiations over doc pay, health cent...

Jan 18, 2024